Leflunomide and Laryngeal pain - a phase IV clinical study of FDA data
Laryngeal pain is found among people who take Leflunomide, especially for people who are female, 50-59 old.
The phase IV clinical study analyzes which people take Leflunomide and have Laryngeal pain. It is created by eHealthMe based on reports of 67,544 people who have side effects when taking Leflunomide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
67,544 people reported to have side effects when taking Leflunomide.
Among them, 8 people (0.01%) have Laryngeal pain.
What is Leflunomide?
Leflunomide has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 67,910 Leflunomide users for its effectiveness, alternative drugs and more.
What is Laryngeal pain?
Laryngeal pain is found to be associated with 298 drugs and 138 conditions by eHealthMe.
Number of Leflunomide and Laryngeal pain reports submitted per year:
Gender of people who have Laryngeal pain when taking Leflunomide *:
- female: 100 %
- male: 0.0 %
Age of people who have Laryngeal pain when taking Leflunomide *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 100 %
- 60+: 0.0 %
Common drugs people take besides Leflunomide *:
- Xeljanz Xr: 8 people, 100.00%
- Proair Hfa: 8 people, 100.00%
- Xeljanz: 1 person, 12.50%
- Vitamin D3: 1 person, 12.50%
Common side effects people have besides Laryngeal pain *:
- Pain In Extremity: 8 people, 100.00%
- Hypoaesthesia (reduced sense of touch or sensation): 8 people, 100.00%
- Drug Ineffective: 8 people, 100.00%
- Bronchitis Viral (inflammation of the mucous membrane in the bronchial tubes due to infection with streptococcus pneumoniae): 7 people, 87.50%
- Dizziness: 6 people, 75.00%
- The Flu (the flu is caused by an influenza virus): 4 people, 50.00%
- Breast Lump (localized swelling that feels different from the surrounding breast tissue): 3 people, 37.50%
* Approximation only. Some reports may have incomplete information.
Do you take Leflunomide and have Laryngeal pain?Check whether Laryngeal pain is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Laryngeal pain and when was it recovered:
Expand to all the drugs that have ingredients of leflunomide:
Alternative drugs to, pros and cons of Leflunomide:
- Leflunomide (67,910 reports)
Common Leflunomide side effects:
- Drug ineffective: 30,964 reports
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 19,759 reports
- Pain: 13,190 reports
- Joint swelling: 12,445 reports
- Joint pain: 11,761 reports
- Rashes (redness): 10,266 reports
- Fatigue (feeling of tiredness): 9,884 reports
Browse all side effects of Leflunomide:a b c d e f g h i j k l m n o p q r s t u v w x y z
Laryngeal pain treatments and more:
- Laryngeal pain (413 reports)
COVID vaccines that are related to Laryngeal pain:
- Laryngeal pain in Moderna COVID Vaccine
- Laryngeal pain in Pfizer BioNTech Covid Vaccine
- Laryngeal pain in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Laryngeal pain:
- Laryngeal pain (298 drugs)
All the conditions that are associated with Laryngeal pain:
- Laryngeal pain (138 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on leflunomide (the active ingredients of Leflunomide) and Leflunomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Dupixent and Trospium Chloride drug interaction - 2 seconds ago
- Metronidazole Hydrochloride and Diarrhea - 2 seconds ago
- Metronidazole Hydrochloride and Stools - Watery - 2 seconds ago
- Relafen and Cerebral Arteriosclerosis - 4 seconds ago
- Colace and Synthroid drug interaction - 8 seconds ago
- Nitro-Dur and Nosebleed - 22 seconds ago
- Keppra and Renal Failure - Acute - 36 seconds ago
- Keppra and Acute Kidney Failure - 36 seconds ago
- Cialis and Sleep Walking - 45 seconds ago
- Palonosetron and Roxicodone drug interaction - 47 seconds ago